BGM GROUP LTD (BGM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BGM • KYG7307E1237

1.48 USD
-0.91 (-38.08%)
At close: Feb 4, 2026
1.58 USD
+0.1 (+6.76%)
After Hours: 2/4/2026, 8:05:11 PM
Fundamental Rating

2

Overall BGM gets a fundamental rating of 2 out of 10. We evaluated BGM against 191 industry peers in the Pharmaceuticals industry. The financial health of BGM is average, but there are quite some concerns on its profitability. BGM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year BGM has reported negative net income.
  • BGM had a negative operating cash flow in the past year.
  • In multiple years BGM reported negative net income over the last 5 years.
  • Each year in the past 5 years BGM had a positive operating cash flow.
BGM Yearly Net Income VS EBIT VS OCF VS FCFBGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

  • BGM has a better Return On Assets (-1.31%) than 75.92% of its industry peers.
  • BGM's Return On Equity of -1.49% is fine compared to the rest of the industry. BGM outperforms 78.01% of its industry peers.
Industry RankSector Rank
ROA -1.31%
ROE -1.49%
ROIC N/A
ROA(3y)-5.41%
ROA(5y)-0.31%
ROE(3y)-6.51%
ROE(5y)1.12%
ROIC(3y)N/A
ROIC(5y)N/A
BGM Yearly ROA, ROE, ROICBGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • BGM has a Gross Margin of 19.41%. This is comparable to the rest of the industry: BGM outperforms 53.40% of its industry peers.
  • In the last couple of years the Gross Margin of BGM has declined.
  • BGM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.4%
GM growth 5Y-4.83%
BGM Yearly Profit, Operating, Gross MarginsBGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

5

2. Health

2.1 Basic Checks

  • BGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BGM has less shares outstanding
  • The number of shares outstanding for BGM has been reduced compared to 5 years ago.
  • BGM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BGM Yearly Shares OutstandingBGM Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BGM Yearly Total Debt VS Total AssetsBGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • BGM has an Altman-Z score of 9.47. This indicates that BGM is financially healthy and has little risk of bankruptcy at the moment.
  • BGM's Altman-Z score of 9.47 is amongst the best of the industry. BGM outperforms 81.68% of its industry peers.
  • BGM has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of BGM (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 9.47
ROIC/WACCN/A
WACC8.15%
BGM Yearly LT Debt VS Equity VS FCFBGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that BGM should not have too much problems paying its short term obligations.
  • BGM has a worse Current ratio (1.82) than 64.92% of its industry peers.
  • BGM has a Quick Ratio of 1.45. This is a normal value and indicates that BGM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.45, BGM is not doing good in the industry: 62.83% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.45
BGM Yearly Current Assets VS Current LiabilitesBGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

  • BGM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.40%, which is quite impressive.
  • Looking at the last year, BGM shows a very negative growth in Revenue. The Revenue has decreased by -10.12% in the last year.
  • The Revenue for BGM have been decreasing by -11.45% on average. This is quite bad
EPS 1Y (TTM)74.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.9%
Revenue 1Y (TTM)-10.12%
Revenue growth 3Y-23.97%
Revenue growth 5Y-11.45%
Sales Q2Q%13.92%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BGM Yearly Revenue VS EstimatesBGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BGM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BGM Price Earnings VS Forward Price EarningsBGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BGM Per share dataBGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • BGM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BGM GROUP LTD

NASDAQ:BGM (2/4/2026, 8:05:11 PM)

After market: 1.58 +0.1 (+6.76%)

1.48

-0.91 (-38.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-24
Earnings (Next)N/A
Inst Owners0.2%
Inst Owner ChangeN/A
Ins Owners25.02%
Ins Owner ChangeN/A
Market Cap240.44M
Revenue(TTM)26.85M
Net Income(TTM)-2.72M
AnalystsN/A
Price TargetN/A
Short Float %0.14%
Short Ratio4.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.96
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 5.69
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.17
BVpS1.12
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.31%
ROE -1.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.41%
FCFM N/A
ROA(3y)-5.41%
ROA(5y)-0.31%
ROE(3y)-6.51%
ROE(5y)1.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.4%
GM growth 5Y-4.83%
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.04%
Cap/Sales 6.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.45
Altman-Z 9.47
F-Score3
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)184.23%
Cap/Depr(5y)176.99%
Cap/Sales(3y)4.89%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.12%
Revenue growth 3Y-23.97%
Revenue growth 5Y-11.45%
Sales Q2Q%13.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.33%
OCF growth 3Y15.85%
OCF growth 5YN/A

BGM GROUP LTD / BGM FAQ

Can you provide the ChartMill fundamental rating for BGM GROUP LTD?

ChartMill assigns a fundamental rating of 2 / 10 to BGM.


Can you provide the valuation status for BGM GROUP LTD?

ChartMill assigns a valuation rating of 0 / 10 to BGM GROUP LTD (BGM). This can be considered as Overvalued.


Can you provide the profitability details for BGM GROUP LTD?

BGM GROUP LTD (BGM) has a profitability rating of 2 / 10.


How financially healthy is BGM GROUP LTD?

The financial health rating of BGM GROUP LTD (BGM) is 5 / 10.